The investigational radioisotope, F-18 FLT (fluorothymidine), is showing promise in clinical trials in the ability to assess response to cancer treatment. Research into the clinical applications of the FLT radiotracer has been underway for over 10 years. After FDA approval for use in clinical trials, the molecular imaging community is holding much promise in the
F-18 FLT: Imaging cell proliferation in contrast to cell metabolism in PET tumor imaging
Gamma Imaging Makes Waves in Women’s Health: Molecular Breast Imaging Improves Breast Cancer Detection
New technologies in nuclear breast imaging could mean a huge increase in accurate detection of breast cancer. Recent findings show MDI to detect 3 times as many malignancies with a higher PPV. By Maggie E. Mason